Latest Insider Transactions at Igm Biosciences, Inc. (IGMS)
This section provides a real-time view of insider transactions for Igm Biosciences, Inc. (IGMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IGM Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IGM Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 09
2020
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
535
-100.0%
|
-
|
|
Oct 02
2020
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,830
-1.55%
|
$133,590
$73.5 P/Share
|
|
Oct 01
2020
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
178
+25.0%
|
-
|
|
Oct 01
2020
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-0.85%
|
$77,520
$76.13 P/Share
|
|
Oct 01
2020
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,850
+2.33%
|
$2,850
$1.39 P/Share
|
|
Oct 01
2020
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
1,000
-34.53%
|
$73,000
$73.59 P/Share
|
|
Oct 01
2020
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
357
+0.38%
|
-
|
|
Oct 01
2020
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
535
+50.0%
|
-
|
|
Oct 01
2020
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
357
+1.0%
|
-
|
|
Oct 01
2020
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
178
+0.32%
|
-
|
|
Oct 01
2020
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
446
+0.05%
|
-
|
|
Oct 01
2020
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
178
+0.01%
|
-
|
|
Sep 09
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
23,260
+0.34%
|
$1,209,520
$52.4 P/Share
|
|
Sep 08
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
47,113
+1.37%
|
$2,308,537
$49.91 P/Share
|
|
Sep 04
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
74,433
+2.17%
|
$3,721,650
$50.28 P/Share
|
|
Sep 03
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
74,253
+2.21%
|
$3,564,144
$48.69 P/Share
|
|
Sep 02
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
20,637
+0.32%
|
$949,302
$46.15 P/Share
|
|
Sep 01
2020
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
41,759
+1.29%
|
$1,837,396
$44.84 P/Share
|
|
Jul 17
2020
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
535
+33.33%
|
-
|
|
Jul 17
2020
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
535
-100.0%
|
-
|
|
Jul 01
2020
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
446
+0.05%
|
-
|
|
Jul 01
2020
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
178
+0.01%
|
-
|
|
Apr 01
2020
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
446
+0.05%
|
-
|
|
Apr 01
2020
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
178
+0.01%
|
-
|
|
Sep 20
2019
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,144,000
+50.0%
|
$50,304,000
$16.0 P/Share
|
|
Sep 20
2019
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
3,144,000
+50.0%
|
$50,304,000
$16.0 P/Share
|